Octreotide LAR and Prednisone as Neoadjuvant Treatment in Patients with Primary or Locally Recurrent Unresectable Thymic Tumors: A Phase II Study

Therapeutic options to cure advanced, recurrent, and unresectable thymomas are limited. The most important factor for long-term survival of thymoma patients is complete resection (R0) of the tumor. We therefore evaluated the response to and the induction of resectability of primarily or locally recu...

Descripción completa

Detalles Bibliográficos
Autores principales: Kirzinger, Lukas, Boy, Sandra, Marienhagen, Jörg, Schuierer, Gerhard, Neu, Reiner, Ried, Michael, Hofmann, Hans-Stefan, Wiebe, Karsten, Ströbel, Philipp, May, Christoph, Kleylein-Sohn, Julia, Baierlein, Claudia, Bogdahn, Ulrich, Marx, Alexander, Schalke, Berthold
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2016
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5161359/
https://www.ncbi.nlm.nih.gov/pubmed/27992479
http://dx.doi.org/10.1371/journal.pone.0168215

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5161359/
https://www.ncbi.nlm.nih.gov/pubmed/27992479
http://dx.doi.org/10.1371/journal.pone.0168215

Ejemplares similares